A Prospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia
Condition: 2019-nCoV Interventions: Drug: Abidol hydrochloride; Drug: Oseltamivir; Drug: Lopinavir/ritonavir Sponsor: Tongji Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Antiviral Therapy | COVID-19 | Hospitals | Kaletra | Norvir | Oseltamivir | Pneumonia | Research | Study | Tamiflu